DOH: WHO “solidarity trials” for COVID-19 vaccine could begin until the end of October

MANILA, Philippines – World Health Organization (WHO) “solidarity trials” for possible coronavirus vaccines could begin in the Philippines until the last week of October, Undersecretary of Health Maria Rosario Vergeire said Friday.

“Tinitingnan natin ‘yung third or fourth week of October for maumpisahan ito, kasi una his pilot site pagkatapos all the sites that have already been known are already asasama na, so we are in the third to fourth week of October for this,” he said Array Vergeire to journalists. . briefing when asked about the solidarity events calendar.

Vergeire said the dates were released at an assembly of the country’s sub-technical organization for vaccines, where WHO provided the main points on the timetable for trials.

However, he noted that dates could be an issue to replace due to imaginable “intermediate factors”.

According to Vergeire, WHO does not yet know which of the 34 vaccines will be included in this initiative.

The government has already known 8 vaccine testing spaces, consisting of six in the metropolitan domain of Manila and one in Calabarzon and Cebu, according to the Secretary of Science and Technology, Fortunato dela Pea.

Meanwhile, Vergeire said the country’s organization of vaccine experts had already reviewed and commented on the documents presented through the Gamaleya Research Institute in Epidemiology and Microbiology that developed the Sputnik V vaccine in Russia.

He said he’s now waiting for the high school’s reaction to his comments.

The Inquirer Foundation supports our leaders in the fitness sector and still accepts donations of money to be deposited into the Golden Bank Current Account (BDO) – 007960018860 or to make a donation through PayMaya this link.

We use cookies in the most productive way on our website. By continuing, you are satisfied with our use of cookies. For more information, click this link.

Leave a Comment

Your email address will not be published. Required fields are marked *